Chronic inflammation is probably the biggest driver, whether from gut infections like SIBO or candida, autoimmune conditions, or persistent immune activation
The exact shelf life depends on the peptide, solvent, sterility, concentration, light exposure, and handling
For patients seeking affordable GLP-1 therapy today, compounded versions provide a legal, regulated alternative that does not require waiting for patent expiration
Winning DoD R&D Funding: SBIR, BAAs, OTAs, and the Opportunities Most Companies Miss The Department of Defense invests billions of dollars in research and development each year ($141.2B in FY2025) and a significant share of that flows directly to private industry